S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 10.9 CNY 0.18% Market Closed
Market Cap: 7.2B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shandong Sinobioway Biomedicine Co Ltd stock under the Base Case scenario is 3.11 CNY. Compared to the current market price of 10.9 CNY, Shandong Sinobioway Biomedicine Co Ltd is Overvalued by 71%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3.11 CNY
Overvaluation 71%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Shandong Sinobioway Biomedicine Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Shandong Sinobioway Biomedicine Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Shandong Sinobioway Biomedicine Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Shandong Sinobioway Biomedicine Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

10.9 CNY
+0.18%
+0.18%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Shandong Sinobioway Biomedicine Co Ltd
CN
Chemicals
Market Cap
7.2B CNY
IPO
May 20, 2011
Employees
653
China
Market Cap
7.2B CNY
Industry
Chemicals
IPO
May 20, 2011
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Shandong Sinobioway Biomedicine Co Ltd

Provide an overview of the primary business activities
of Shandong Sinobioway Biomedicine Co Ltd.

What unique competitive advantages
does Shandong Sinobioway Biomedicine Co Ltd hold over its rivals?

What risks and challenges
does Shandong Sinobioway Biomedicine Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shandong Sinobioway Biomedicine Co Ltd.

Provide P/S
for Shandong Sinobioway Biomedicine Co Ltd.

Provide P/E
for Shandong Sinobioway Biomedicine Co Ltd.

Provide P/OCF
for Shandong Sinobioway Biomedicine Co Ltd.

Provide P/FCFE
for Shandong Sinobioway Biomedicine Co Ltd.

Provide P/B
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/S
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/GP
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/EBITDA
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/EBIT
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/OCF
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/FCFF
for Shandong Sinobioway Biomedicine Co Ltd.

Provide EV/IC
for Shandong Sinobioway Biomedicine Co Ltd.

What are the Revenue projections
for Shandong Sinobioway Biomedicine Co Ltd?

How accurate were the past Revenue estimates
for Shandong Sinobioway Biomedicine Co Ltd?

What are the Net Income projections
for Shandong Sinobioway Biomedicine Co Ltd?

How accurate were the past Net Income estimates
for Shandong Sinobioway Biomedicine Co Ltd?

What are the EPS projections
for Shandong Sinobioway Biomedicine Co Ltd?

How accurate were the past EPS estimates
for Shandong Sinobioway Biomedicine Co Ltd?

What are the EBIT projections
for Shandong Sinobioway Biomedicine Co Ltd?

How accurate were the past EBIT estimates
for Shandong Sinobioway Biomedicine Co Ltd?

Compare the revenue forecasts
for Shandong Sinobioway Biomedicine Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shandong Sinobioway Biomedicine Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shandong Sinobioway Biomedicine Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shandong Sinobioway Biomedicine Co Ltd compared to its peers.

Compare the P/E ratios
of Shandong Sinobioway Biomedicine Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shandong Sinobioway Biomedicine Co Ltd with its peers.

Analyze the financial leverage
of Shandong Sinobioway Biomedicine Co Ltd compared to its main competitors.

Show all profitability ratios
for Shandong Sinobioway Biomedicine Co Ltd.

Provide ROE
for Shandong Sinobioway Biomedicine Co Ltd.

Provide ROA
for Shandong Sinobioway Biomedicine Co Ltd.

Provide ROIC
for Shandong Sinobioway Biomedicine Co Ltd.

Provide ROCE
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Gross Margin
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Operating Margin
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Net Margin
for Shandong Sinobioway Biomedicine Co Ltd.

Provide FCF Margin
for Shandong Sinobioway Biomedicine Co Ltd.

Show all solvency ratios
for Shandong Sinobioway Biomedicine Co Ltd.

Provide D/E Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

Provide D/A Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Interest Coverage Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Altman Z-Score Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Quick Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Current Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

Provide Cash Ratio
for Shandong Sinobioway Biomedicine Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shandong Sinobioway Biomedicine Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shandong Sinobioway Biomedicine Co Ltd?

What is the current Free Cash Flow
of Shandong Sinobioway Biomedicine Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shandong Sinobioway Biomedicine Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shandong Sinobioway Biomedicine Co Ltd

Current Assets 742.3m
Cash & Short-Term Investments 434.4m
Receivables 225.1m
Other Current Assets 82.8m
Non-Current Assets 1.5B
Long-Term Investments 1.1B
PP&E 314.9m
Intangibles 104.4m
Other Non-Current Assets 19.5m
Current Liabilities 86.2m
Accounts Payable 35.1m
Accrued Liabilities 8.2m
Short-Term Debt 10m
Other Current Liabilities 32.9m
Non-Current Liabilities 139.9m
Long-Term Debt 320.4k
Other Non-Current Liabilities 139.6m
Efficiency

Earnings Waterfall
Shandong Sinobioway Biomedicine Co Ltd

Revenue
431.4m CNY
Cost of Revenue
-91.1m CNY
Gross Profit
340.3m CNY
Operating Expenses
-740.9m CNY
Operating Income
-400.7m CNY
Other Expenses
92.3m CNY
Net Income
-308.3m CNY

Free Cash Flow Analysis
Shandong Sinobioway Biomedicine Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shandong Sinobioway Biomedicine Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
Declining ROIC
30/100
Profitability
Score

Shandong Sinobioway Biomedicine Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shandong Sinobioway Biomedicine Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Shandong Sinobioway Biomedicine Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shandong Sinobioway Biomedicine Co Ltd

There are no price targets for Shandong Sinobioway Biomedicine Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shandong Sinobioway Biomedicine Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shandong Sinobioway Biomedicine Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Shandong Sinobioway Biomedicine Co Ltd stock?

The intrinsic value of one Shandong Sinobioway Biomedicine Co Ltd stock under the Base Case scenario is 3.11 CNY.

Is Shandong Sinobioway Biomedicine Co Ltd stock undervalued or overvalued?

Compared to the current market price of 10.9 CNY, Shandong Sinobioway Biomedicine Co Ltd is Overvalued by 71%.

Back to Top